IMPAX Laboratories (IPXL) Receives FDA Approval for Generic Colestid
Tweet Send to a Friend
IMPAX Laboratories, Inc. (OTC: IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


